TL/DR –
Qure.ai, a medical imaging AI provider, has raised $65 million in a Series D funding round spearheaded by Lightspeed and 360 ONE Asset, with contributions from Merck Global Health Innovation Fund, Kae Capital, Novo Holdings, Health Quad, and TeamFund. The raised capital will be used to accelerate its expansion into the U.S. market and other regions, enhance investments in AI models and enable acquisitions of complementary med-tech companies. The company, founded in 2016, deploys its solutions in over 90 countries across more than 3,000 sites, aiming to improve the identification and management of critical diseases.
Qure.ai Secures $65 Million in Series D Funding
Qure.ai, the global provider of AI medical imaging solutions, has raised $65 million in a Series D funding round. This round was led by Lightspeed and 360 ONE Asset, and also saw participation from Merck Global Health Innovation Fund, Kae Capital, Novo Holdings, Health Quad, and TeamFund. The raised funds will be utilized to accelerate expansion, notably into the U.S. market, increase investment in fundamental AI models, and facilitate acquisitions of complementary med-tech companies.
With its solutions deployed across more than 3,000 sites in 90 countries, Qure.ai is a trusted partner of healthcare organizations worldwide. “AI helps overcome healthcare bottlenecks, from imaging reporting backlogs and low screening uptakes to workforce resource constraints,” noted Qure.ai Co-Founder/CEO Prashant Warier. They also partner with top pharma and medtech companies, like Medtronic and J&J, to expedite early disease diagnosis and treatment.
Established in 2016, the Mumbai-based Qure.ai is revolutionizing healthcare accessibility and equitability with its AI-powered diagnosis tools. Its products, which have gained 18 U.S. FDA clearance indications and Class IIb certification per EU MDR regulations, aid in the efficient detection and management of critical diseases. Qure.ai also operates regional offices in New York, London, and Dubai.
“We are excited to back Qure.ai, a leader in AI-driven healthcare diagnostics,” said Lightspeed Partner Dev Khare. Equally thrilled is 360 ONE Asset Fund Manager Tarun Sharma, who said, “Qure is leading the way in making the impactful use of AI in healthcare a reality.”
Qure.ai is disrupting the radiology status quo, enhancing imaging accuracy, and improving health outcomes with its AI-integrated tools. Availing of deep learning technology, Qure.ai’s automated interpretation of radiology exams aids medical imaging professionals in faster diagnosis and treatment initiation.
—
Read More Health & Wellness News ; US News